-

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of SentinelOne, Inc. (S) Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired SentinelOne, Inc. (“SentinelOne” or the “Company”) (NYSE: S) securities during the period from June 1, 2022 through June 1, 2023 (the “Class Period”). Investors have until August 7, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

SentinelOne develops security platforms to protect organizations against advanced threats and malware.

On June 1, 2023, after the market closed, SentinelOne published a press release titled “SentinelOne Announces First Quarter Fiscal Year 2024 Financial Results.” Therein, the Company stated that “[a]s a result of a change in methodology and correction of historical inaccuracies . . . [the Company has] made a one-time adjustment to ARR of $27.0 million[.]” On this news, the price of SentinelOne shares declined by $7.28 per share, or approximately 35.14%, from $20.72 per share to close at $13.44 on June 2, 2023.

The lawsuit alleges that, throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose that: (1) SentinelOne lacked effective internal controls over accounting and financial reporting; (2) as a result, the Company’s ARR was overstated; and (3) as a result, the Company’s guidance was overstated.

If you purchased or otherwise acquired SentinelOne securities, have information, or would like to learn more about this lawsuit and how it might affect your rights, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: http://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NYSE:S

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Social Media Profiles
More News From Kirby McInerney LLP

RAL INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Ralliant Corporation

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Ralliant Corporation (“Ralliant” or the “Company”) (NYSE:RAL) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On February 4, 2026, Ralliant reported fourth quarter and full year 2025 results, revealing a “$1.4 billion non-cas...

KDDIY INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving KDDI Corporation

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of KDDI Corporation (“KDDI” or the “Company”) (OTC:KDDIY) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On February 6, 2026, KDDI posted an announcement on its website entitled “Notice Regarding Expectation that Disclosure of...

INVESTOR ALERT: Securities Class Action Filed Against Corcept Therapeutics Incorporated – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ:CORT) securities during the period of October 31, 2024 through December 30, 2025, inclusive (“the Class Period”). If you suffered a loss on your Corcept investments, you have until April 21, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff app...
Back to Newsroom